Methylphenylsuccinimide
Categorie
Methylphenylsuccinimide Les marques, Methylphenylsuccinimide Analogs
- (+/-)-N-Methyl-2-phenylsuccinimide
- 1-Methyl-3-Phenylsuccinimide
- Epimid
- Fenosuccimide
- Fensuccimide [DCIT]
- Fensuximida [INN-Spanish]
- Lifene
- Methylphenylsuccinimide
- Milontin
- Milontin (TN)
- Milonton
- Mirontin
- Mirotin;7 Phenosuccimide
- N-Methyl-2-phenylsuccinimide
- N-Methyl-alpha-phenolsuccinimide
- N-Methyl-alpha-phenylsuccinimide
- Phensuximid
- Phensuximide (USP)
- Phensuximide [BAN:INN]
- Phensuximidum [INN-Latin]
- Phenylsuximide
- Succinimide, N-methyl-2-phenyl-
- Succitimal
Methylphenylsuccinimide Les marques melange
Methylphenylsuccinimide Formule chimique
C11H11NO2
Methylphenylsuccinimide RX lien
No information avaliable
Methylphenylsuccinimide FDA fiche
Methylphenylsuccinimide msds (fiche de securite des materiaux)
Methylphenylsuccinimide Synthese de reference
Aucune information disponible
Methylphenylsuccinimide Poids moleculaire
189.211 g/mol
Methylphenylsuccinimide Point de fusion
72 oC
Methylphenylsuccinimide H2O Solubilite
7020 mg / L
Methylphenylsuccinimide Etat
Solid
Methylphenylsuccinimide LogP
1.079
Methylphenylsuccinimide Formes pharmaceutiques
Capsules
Methylphenylsuccinimide Indication
Pour le traitement de l'épilepsie
Methylphenylsuccinimide Pharmacologie
Phensuximide supprime la paroxystique cycle de trois par seconde vague de pointe et pattern EEG associé à des défaillances de la conscience en l'absence (petit mal) saisies. La fréquence des attaques est réduite par la dépression de la transmission nerveuse dans le cortex moteur.
Methylphenylsuccinimide Absorption
Rapide et complète
Methylphenylsuccinimide Toxicite
Aucune information disponible
Methylphenylsuccinimide Information pour les patients
No information avaliable
Methylphenylsuccinimide Organismes affectes
Les humains et autres mammifères
